Search

everythinglearnresearchcommunity

for

Search:↓

All three treatments reduce hirsutism, but spironolactone works best long-term.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Human enzymes can detoxify harmful substances but might also increase their cancer risk.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Finasteride reduces alcohol withdrawal severity in male mice but increases it in female mice.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Oral retinoids may help some patients with hard-to-treat lichen planopilaris, but more research is needed.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Valproate is a mood stabilizer for bipolar disorder but has side effects and risks, especially during pregnancy.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.